Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic immunization of neonates.

Adrian Bot1, Constantin Bona

  • 1Department of Immunology, Alliance Pharmaceutical Corp., 6175 Lusk Blvd, San Diego, CA 92121, USA. axb@allp.com

Microbes and Infection
|April 5, 2002
PubMed
Summary

Neonatal vaccination using plasmid DNA vaccines effectively stimulates robust immune responses, overcoming challenges like maternal antibodies and immune immaturity. This approach offers a promising strategy for early-life immunization against pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-T cells targeting fibroblast activation protein eliminate pathological fibroblasts and preserve cardiac function in a Duchenne Muscular Dystrophy murine model.

Stem cell research & therapy·2026
Same author

Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.

Cancer immunology research·2026
Same author

The dawn of in vivo immune cell engineering in oncology.

Nature biotechnology·2026
Same author

Accelerating progress in immune cell therapy for solid tumours.

Nature reviews. Drug discovery·2025
Same author

In vivo chimeric antigen receptor (CAR)-T cell therapy.

Nature reviews. Drug discovery·2025
Same author

Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2024

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Neonatal vaccination is challenging due to immature immune systems, tolerance susceptibility, and maternal antibody interference.
  • Plasmid DNA vaccines have shown potential in preclinical models to overcome these neonatal hurdles.

Purpose of the Study:

  • To evaluate the efficacy of plasmid DNA vaccines in inducing neonatal immunity.
  • To explore the mechanisms underlying DNA vaccine immunogenicity in neonates.

Main Methods:

  • Studies in rodents and non-human primates using plasmid vaccines expressing microbial antigens.
  • Analysis of humoral and cellular immune responses, including Th1 component.
  • Investigation of the role of bacterial CpG motifs and antigen-presenting cell activation.

Main Results:

  • Plasmid vaccines induced significant humoral and cellular immunity, including a Th1 response, without causing tolerance.
  • Bacterial CpG motifs were critical for activating immature antigen-presenting cells, enhancing neonatal immunogenicity.
  • Endogenous antigen production post-transfection appeared to overcome maternal antibody inhibition of cellular responses.

Conclusions:

  • Plasmid DNA vaccines are a promising strategy for priming neonatal immune responses against pathogens.
  • DNA vaccine regimens, potentially combined with conventional vaccines, may offer superior immunity.
  • Understanding plasmid vector immunomodulatory properties could lead to early prophylaxis of inflammatory disorders.

Related Experiment Videos